Cerebrotendinous xanthomatosis: a treatable ataxia.
Clemen
C S
CS
Center for Biochemistry, Medical Faculty, University of Cologne, Joseph-Stelzmann-Str. 52, 50931 Koeln, Germany. christoph.clemen@uni-koeln.de
Spottke
E A
EA
Lütjohann
D
D
Urbach
H
H
von Bergmann
K
K
Klockgether
T
T
Dodel
R
R
D000328:Adult; D002524:Cerebellar Ataxia / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology*; D002531:Cerebellum / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology*; D002635:Chenodeoxycholic Acid / Q000008:administration & dosage; D004083:Cholestanol / Q000097:blood; D002784:Cholesterol / Q000378:metabolism; D018450:Disease Progression; D004569:Electroencephalography; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D020336:Paraparesis, Spastic / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D019821:Simvastatin / Q000008:administration & dosage; D016896:Treatment Outcome; D019294:Xanthomatosis, Cerebrotendinous / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*
D002635:Chenodeoxycholic Acid; D004083:Cholestanol; D002784:Cholesterol; D019821:Simvastatin